Eva C. Jensen

3.5k total citations · 1 hit paper
21 papers, 796 citations indexed

About

Eva C. Jensen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Eva C. Jensen has authored 21 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in Eva C. Jensen's work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Coronary Interventions and Diagnostics (6 papers). Eva C. Jensen is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Coronary Interventions and Diagnostics (6 papers). Eva C. Jensen collaborates with scholars based in Sweden, United Kingdom and United States. Eva C. Jensen's co-authors include Robert F. Storey, Philippe Gabríel Steg, Marc S. Sabatine, Deepak L. Bhatt, Marc P. Bonaca, Marc Cohen, Peter Held, Eugene Braunwald, Karin Wåhlander and Alexander Parkhomenko and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Eva C. Jensen

20 papers receiving 768 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

2016 249 citations Marc P. Bonaca, Deepak L. Bhatt et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Eva C. Jensen

Since Specialization

Citations

This map shows the geographic impact of Eva C. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva C. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva C. Jensen more than expected).

Fields of papers citing papers by Eva C. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva C. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva C. Jensen. The network helps show where Eva C. Jensen may publish in the future.

Co-authorship network of co-authors of Eva C. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva C. Jensen. A scholar is included among the top collaborators of Eva C. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva C. Jensen. Eva C. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 2019 ·European Heart Journal ·Remo H.M. Furtado, José Carlos Nicolau, Giulia Magnani, KyungAh Im, Deepak L. Bhatt, Robert F. Storey, Philippe Gabríel Steg, Jindřich Špinar, Andrzej Budaj, Frederic Kontny, Ramón Corbalán, Róbert Gábor Kiss, Maria Teresa B. Abola, Per Johanson, Eva C. Jensen, Eugene Braunwald, Marc S. Sabatine, Marc P. Bonaca	15
2	Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease 2018 ·Journal of the American College of Cardiology ·Sameer Bansilal, Marc P. Bonaca, Jan H. Cornel, Robert F. Storey, Deepak L. Bhatt, Philippe Gabríel Steg, KyungAh Im, Sabina A. Murphy, Dominick J. Angiolillo, Róbert Gábor Kiss, Alexander Parkhomenko, José López‐Sendón, Daniel Isaza, Assen Goudev, Frederic Kontny, Peter Held, Eva C. Jensen, Eugene Braunwald, Marc S. Sabatine, (unknown)	43
3	Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54 2017 ·Journal of the American College of Cardiology ·Marc P. Bonaca, Robert F. Storey, Pierre Théroux, Philippe Gabríel Steg, Deepak L. Bhatt, Marc Cohen, KyungAh Im, Sabina A. Murphy, Giulia Magnani, Ton Oude Ophuis, (unknown), Alexander Parkhomenko, Daniel Isaza, Gabriel Kamenský, Assen Goudev, Gilles Montalescot, Eva C. Jensen, Per Johanson, Eugene Braunwald, Marc S. Sabatine	52
4	2864Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 2017 ·European Heart Journal ·Marc P. Bonaca, Petr Jarolı́m, Erica L. Goodrich, Robert F. Storey, Deepak L. Bhatt, Philippe Gabríel Steg, Marc Cohen, Eva C. Jensen, Per Johanson, Eugene Braunwald, David A. Morrow, Marc S. Sabatine, (unknown)	0
5	EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL 2016 ·Journal of the American College of Cardiology ·Sameer Bansilal, Marc P. Bonaca, Jan H. Cornel, Robert F. Storey, Deepak L. Bhatt, Philippe Gabríel Steg, (unknown), Peter Held, Eva C. Jensen, Eugene Braunwald, Marc S. Sabatine, Ton Oude Ophuis	3
6	Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease breakdown → 2016 ·Journal of the American College of Cardiology ·Marc P. Bonaca, Deepak L. Bhatt, Robert F. Storey, Philippe Gabríel Steg, Marc Cohen, Julia Kuder, Erica L. Goodrich, José Carlos Nicolau, Alexander Parkhomenko, José López‐Sendón, Mikael Dellborg, Anthony J. Dalby, Jindřich Špinar, Philip E. Aylward, Ramón Corbalán, Maria Teresa B. Abola, Eva C. Jensen, Peter Held, Eugene Braunwald, Marc S. Sabatine	249
7	EFFICACY AND SAFETY OF TICAGRELOR AS LONG-TERM SECONDARY PREVENTION IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION AND PERIPHERAL ARTERY DISEASE 2016 ·Journal of the American College of Cardiology ·Marc P. Bonaca, Deepak L. Bhatt, Robert F. Storey, Philippe Gabríel Steg, Marc Cohen, Julia Kuder, KyungAh Im, Peter Held, Eva C. Jensen, Eugene Braunwald, Marc S. Sabatine	12
8	Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction 2016 ·Circulation ·Marc P. Bonaca, Shinya Goto, Deepak L. Bhatt, Philippe Gabríel Steg, Robert F. Storey, Marc Cohen, Erica L. Goodrich, Laura Mauri, Ton Oude Ophuis, Mikhail Ruda, Jindřich Špinar, Ki‐Bae Seung, Dayi Hu, Anthony J. Dalby, Eva C. Jensen, Peter Held, David A. Morrow, Eugene Braunwald, Marc S. Sabatine	31
9	TCT-78 Efficacy of Long-Term Ticagrelor in Stented Patients in PEGASUS-TIMI 54 2015 ·Journal of the American College of Cardiology ·Marc P. Bonaca, Deepak L. Bhatt, Philippe Gabríel Steg, Andrzej Budaj, Sameer Bansilal, Robert F. Storey, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, (unknown), Christian W. Hamm, Jindřich Špinar, Róbert Gábor Kiss, Rafael Díaz, Frans Van de Werf, Gilles Montalescot, Eva C. Jensen, Peter Held, Eugene Braunwald, Marc S. Sabatine	5
10	Exposure–response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation 2015 ·British Journal of Clinical Pharmacology ·Gregory Y.H. Lip, Lars Hvilsted Rasmussen, Sandra Olsson, Eva C. Jensen, Bengt Hamrén, Ulf G. Eriksson, Karin Wåhlander	3
11	Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial 2014 ·American Heart Journal ·Marc P. Bonaca, Deepak L. Bhatt, Eugene Braunwald, Marc Cohen, Philippe Gabríel Steg, Robert F. Storey, Peter Held, Eva C. Jensen, Marc S. Sabatine	73
12	Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjects 2011 ·International Journal of Clinical Pharmacology and Therapeutics ·Susanne Johansson, Marie Cullberg, Ulf G. Eriksson, Margareta Elg, (unknown), Eva C. Jensen, (unknown), (unknown)	15
13	Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation 2010 ·Thrombosis and Haemostasis ·(unknown), Arnljot Tveit, Eva C. Jensen, Peter Wessman, (unknown), Karin Wåhlander, (unknown)	47
14	Adenosine A₁receptor mediated suppression of adrenal activity in near-term fetal sheep 2010 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Eva C. Jensen, Laura Bennet, Mhoyra Fraser, Gordon G. Power, Christian J. Hunter, Alistair J. Gunn	8
15	Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists 2009 ·European Heart Journal ·Gregory Y.H. Lip, Lars Hvilsted Rasmussen, Sandra Olsson, Eva C. Jensen, (unknown), Ulf G. Eriksson, Karin Wåhlander	78
16	Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran 2008 ·Thrombosis Research ·Giancarlo Agnelli, Bengt I. Eriksson, Alexander T. Cohen, David Bergqvist, O.E. Dahl, Michael R. Lassen, Patrick Mouret, Nadia Rosencher, Magnus Andersson, Anders Bylock, Eva C. Jensen, (unknown)	63
17	Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system 2004 ·The Annals of Thoracic Surgery ·Eva C. Jensen, Svenerik Andréasson, Anders Bengtsson, Håkan Berggren, Rolf Ekroth, Lars E. Larsson, (unknown)	21
18	A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients 2004 ·The Annals of Thoracic Surgery ·(unknown), (unknown), Anders Bengtsson, Rolf Ekroth, Eva C. Jensen, Anders Jeppsson	38
19	Influence of two different perfusion systems on inflammatory response in pediatric heart surgery 2003 ·The Annals of Thoracic Surgery ·Eva C. Jensen, Svenerik Andréasson, Anders Bengtsson, Håkan Berggren, Rolf Ekroth, (unknown), (unknown)	22
20	Increased levels of S‐100 protein after cardiac surgery with cardiopulmonary bypass and general surgery in children 2000 ·Pediatric Anesthesia ·Eva C. Jensen, Kerstin Sandström, Svenerik Andréasson, Krister Nilsson, Håkan Berggren, Lars E. Larsson	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact